← Evidence map

ArticleAdvances in therapy2025

Economic Burden and Provider Referral Patterns Among Patients with Unresectable Stage III EGFR-Mutated NSCLC Receiving Chemoradiotherapy in the United States.

YongJin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Economic Burden and Provider Referral Patterns Among Patients with Unresectable Stage III EGFR-Mutated NSCLC Receiving Chemoradiotherapy in the United States. | OpenQuestion